CJC-1295 without DAC 5mg + Ipamorelin 5mg Co-Formulated Vial

Co-formulated vial containing CJC-1295 without DAC 5mg and Ipamorelin 5mg, for qualified B2B sourcing, with per-component batch documentation and custom fill discussion.

Category
Lyophilized Peptides
Co-formulated vialCJC-1295 no DAC 5mgIpamorelin 5mgPer-component COAResearch use only

Review specifications, files, and next-step support before requesting samples.

  • Confirm the peptide name, CAS, and core specifications
  • Check typical applications and document availability
  • Use one inquiry path for pricing, files, samples, or project discussion

Key Review Snapshot

Key Review Snapshot

Start with the review points that shape quotation quality.These checkpoints help buyers align file scope, vial format, packaging, MOQ, lead time, and buyer-side review before comparing supplier offers.
Product FormatCo-formulated lyophilized peptide vial, two components
Supply FocusQualified B2B sourcing of blended vials, with component-level documentation
DocumentationBatch COA stating RP-HPLC and MS results, plus SDS/MSDS and specification sheet. Karl Fischer water content and counter-ion data are arranged per project where a specification requires them.
Quotation ScopeFill amount, vial count, packaging format, MOQ, and lead time are confirmed together at quotation stage.
PackagingSealed lyophilized vial with stopper and cap. Neutral-label or private-label discussion for qualified projects. Store unopened vials sealed and protected from light and moisture, at 2–8 °C as standard or −20 °C for long-term storage. Shelf life is confirmed for the specific product, packaging configuration, and batch documentation rather than stated here as a general figure.
ComplianceLaboratory research use only; buyer-side market, import, labeling, and downstream compliance review required.

Why buyers trust WUMO

Real content, documented — not guesswork

In this market, “99% pure” is often quoted while the amount actually delivered is far less. We keep purity and real content separate, and put both on paper — so CJC-1295 without DAC 5mg + Ipamorelin 5mg Co-Formulated Vial is backed by documents you can check.

Research peptide line — typical purity >99.3–99.4%, every batch MS-checked before release.

Content equals the label

Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.

Every batch is verified

Identity and quality are confirmed by batch documentation — COA, plus HPLC / MS where applicable — before material is released.

Documented and traceable

Ingredient identity (INCI / CAS), specification sheet and SDS are available for review. Match the documents to your quoted batch before you commit.

Documents Available

Documents Available

View Download Center

COA

Batch-specific COA

Batch-level quality summary for buyer-side file review.

Request this file through the inquiry path below.

HPLC

HPLC purity report

Purity profile reference for the quoted project or batch where available.

Request this file through the inquiry path below.

MS

MS identity report

Identity confirmation support for documentation review where available.

Request this file through the inquiry path below.

SDS

SDS / MSDS

Safety document requested for internal purchasing and handling review.

Request this file through the inquiry path below.

Spec

Product specification sheet

Product or packaging specification reference for quotation alignment.

Request this file through the inquiry path below.

Overview

Overview

A co-formulated lyophilized vial containing Modified GRF (1-29), commercially listed as CJC-1295 without DAC, at 5mg and Ipamorelin at 5mg, supplied for qualified B2B sourcing projects. A blended vial is a different documentation problem from two single vials: the analytical record has to distinguish the two components, and the ratio belongs in the written specification.

B2B Review Guide

B2B Review Guide

Product Overview

This is a co-formulated lyophilized vial containing two peptides: Modified GRF (1-29) — commercially listed as CJC-1295 without DAC — at 5mg, and Ipamorelin at 5mg. It is supplied for qualified B2B research sourcing projects. This page describes sourcing and analytical documentation only; it does not describe biological action, combination rationale, end-user application, or product performance.

What to check on a blended vial that you would not check on a single one

  • Component-level documentation. The analytical record should distinguish the two components and state clearly how identity and purity were assessed for each. Where a component-specific RP-HPLC purity figure is given, the method needs adequate chromatographic separation to support it — a number reported without that separation does not describe either component well.
  • The ratio is part of the specification. 5mg + 5mg and 10mg + 2mg are different products. The ratio belongs in the written specification and on the label, not in a verbal agreement.
  • Total weight is not total peptide. Counterion content, residual moisture, and any excipient sit inside the vial weight. On a two-component vial this arithmetic is easier to get wrong, so confirm what the per-vial claim is measured against.
  • Which CJC-1295. This specification is Modified GRF (1-29), the non-DAC material. Confirm it on the identity record rather than the trade name.

What WUMO Can Supply

  • Co-formulated vials at the 5mg + 5mg specification as standard
  • Alternative ratios and fill quantities by project
  • Batch-specific COA distinguishing the two components
  • Neutral-label or private-label packaging, with components and ratio stated on the label
  • Single-component vials as an alternative — see Modified GRF (1-29) and Ipamorelin
  • MOQ, lead time, and phased delivery planning

Quality and Documentation

A batch-specific COA is issued for the batch being supplied and states the RP-HPLC and mass-spectrometry results for that batch. Purity and peptide content are separate specifications — see what a 10mg vial actually contains for the distinction and what a per-vial claim needs behind it.

Karl Fischer water content, counter-ion form, and appearance are not part of the standard vial COA scope and are arranged per project where a buyer specification requires them. Ask for the COA of the batch being quoted, and check that the batch identifier on it matches the vial label.

Compliance Note

This page is for qualified B2B technical evaluation and business-side documentation review only. Material is supplied for research and laboratory use. It is not intended for individual purchase, consumer use, or product-use guidance, and WUMO does not provide medical guidance or outcome claims. Final use, importation, labeling, and local compliance are the buyer's responsibility.

Frequently Asked Questions

Should a blended vial have one COA or two sets of results?

One COA is fine, but it should distinguish the components and say how identity and purity were assessed for each. A single combined purity figure does not adequately describe the purity of either component.

Can a component-specific purity always be reported?

Only where the analytical method separates the two peptides well enough to support it. Ask what method was used before treating two percentages as equivalent to two single-component COAs.

Can the ratio be changed?

Yes, alternative ratios and fill quantities are set per project. Whatever is agreed should appear in the written specification and on the vial label.

What should I send to get a quotation?

Company and business type, destination market, intended business use, required documentation package, target ratio and fill quantity, vial count, packaging preference, and required timeline.

Specification and documentation references

OEM / Private Label

Want CJC-1295 without DAC 5mg + Ipamorelin 5mg Co-Formulated Vial under your own brand?

For finished lyophilized peptide vials with custom labels and packaging -- covering MOQ, sample or pilot evaluation, and batch documentation such as COA, sterility, and endotoxin reports -- see our private label peptide vial (OEM / ODM) service.

Request Pricing, Files, or Samples

Use this form for pricing, technical files, sample requests, or project discussion for this product.

Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.